Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes

被引：80

作者：

Qi, Yicheng ^{[1
]}

Ma, Jing ^{[1
]}

Li, Shengxian ^{[1
]}

Liu, Wei ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, RenJi Hosp, Dept Internal Med, Div Endocrinol & Metab,Sch Med, 160 Pujian Rd, Shanghai 200127, Peoples R China

来源：

STEM CELL RESEARCH & THERAPY | 2019年 / 10卷 / 01期

基金：

中国国家自然科学基金;

关键词：

T2DM; Insulin resistance; beta cell; MSC therapy; AD-MSCs; BONE-MARROW; STROMAL CELLS; HYPERBARIC-OXYGEN; OXIDATIVE STRESS; TISSUE; TRANSPLANTATION; MELLITUS; EFFICACY; GENERATION; PANCREAS;

D O I：

10.1186/s13287-019-1362-2

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Type 2 diabetes mellitus (T2DM) is mainly characterized by insulin resistance (IR) and impaired insulin secretion. The chronic inflammatory process contributed to IR and could also hamper pancreatic beta cell function. However, currently applied treatment cannot reverse beta cell damage or alleviate inflammation. Mesenchymal stem cells (MSCs), the cell-based therapy for their self-renewable, differentiation potential, and immunosuppressive properties, have been demonstrated in displaying therapeutic effects in T2DM. Adipose-derived MSCs (AD-MSCs) attracted more attention due to less harvested inconvenience and ethical issues commonly accompany with bone marrow-derived MSCs (BM-MSCs) and fetal annex-derived MSCs. Both AD-MSC therapy studies and mechanism explorations in T2DM animals presented that AD-MSCs could translate to clinical application. However, hyperglycemia, hyperinsulinemia, and metabolic disturbance in T2DM are crucial for impairment of AD-MSC function, which may limit the therapeutical effects of MSCs. This review focuses on the outcomes and the molecular mechanisms of MSC therapies in T2DM which light up the hope of AD-MSCs as an innovative strategy to cure T2DM.

引用

页数：13

共 100 条

[1] Adipose Mesenchymal Stromal Cells Isolated From Type 2 Diabetic Patients Display Reduced Fibrinolytic Activity [J].

Acosta, Lourdes ;

Hmadcha, Abdelkrim ;

Escacena, Natalia ;

Perez-Camacho, Inmaculada ;

de la Cuesta, Antonio ;

Ruiz-Salmeron, Rafael ;

Gauthier, Benoit R. ;

Soria, Bernat .

DIABETES, 2013, 62 (12) :4266-4269

[2]

[Anonymous], 1995, Diabetes, V44, P1249

[3] Age-associated changes in the ecological niche: implications for mesenchymal stem cell aging [J].

Asumda, Faizal Z. .

STEM CELL RESEARCH & THERAPY, 2013, 4

[4] Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review [J].

Bacakova, Lucie ;

Zarubova, Jana ;

Travnickova, Martina ;

Musilkova, Jana ;

Pajorova, Julia ;

Slepicka, Petr ;

Kasalkova, Nikola Slepickova ;

Svorcik, Vaclav ;

Kolska, Zdenka ;

Motarjemi, Hooman ;

Molitor, Martin .

BIOTECHNOLOGY ADVANCES, 2018, 36 (04) :1111-1126

[5] Adipose-Derived Mesenchymal Cells for Bone Regereneration: State of the Art [J].

Barba, Marta ;

Cicione, Claudia ;

Bernardini, Camilla ;

Michetti, Fabrizio ;

Lattanzi, Wanda .

BIOMED RESEARCH INTERNATIONAL, 2013, 2013

[6] Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010 [J].

Barton, Franca B. ;

Rickels, Michael R. ;

Alejandro, Rodolfo ;

Hering, Bernhard J. ;

Wease, Stephen ;

Naziruddin, Bashoo ;

Oberholzer, Jose ;

Odorico, Jon S. ;

Garfinkel, Marc R. ;

Levy, Marlon ;

Pattou, Francois ;

Berney, Thierry ;

Secchi, Antonio ;

Messinger, Shari ;

Senior, Peter A. ;

Maffi, Paola ;

Posselt, Andrew ;

Stock, Peter G. ;

Kaufman, Dixon B. ;

Luo, Xunrong ;

Kandeel, Fouad ;

Cagliero, Enrico ;

Turgeon, Nicole A. ;

Witkowski, Piotr ;

Naji, Ali ;

O'Connell, Philip J. ;

Greenbaum, Carla ;

Kudva, Yogish C. ;

Brayman, Kenneth L. ;

Aull, Meredith J. ;

Larsen, Christian ;

Kay, Tom W. H. ;

Fernandez, Luis A. ;

Vantyghem, Marie-Christine ;

Bellin, Melena ;

Shapiro, A. M. James .

DIABETES CARE, 2012, 35 (07) :1436-1445

[7] Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study [J].

Bhansali, Anil ;

Asokumar, Premkumar ;

Walia, Rama ;

Bhansali, Shobhit ;

Gupta, Vivek ;

Jain, Ashish ;

Sachdeva, Naresh ;

Sharma, Rati Ram ;

Marwaha, Neelam ;

Khandelwal, Niranjan .

CELL TRANSPLANTATION, 2014, 23 (09) :1075-1085

[8] Efficacy of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Type 2 Diabetes Mellitus [J].

Bhansali, Anil ;

Upreti, Vimal ;

Khandelwal, N. ;

Marwaha, N. ;

Gupta, Vivek ;

Sachdeva, Naresh ;

Sharma, R. R. ;

Saluja, Karan ;

Dutta, Pinaki ;

Walia, Rama ;

Minz, Ranjana ;

Bhadada, Sanjay ;

Das, Sambit ;

Ramakrishnan, Santosh .

STEM CELLS AND DEVELOPMENT, 2009, 18 (10) :1407-1415

[9] Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study [J].

Bhansali, Shobhit ;

Dutta, Pinaki ;

Kumar, Vinod ;

Yadav, Mukesh Kumar ;

Jain, Ashish ;

Mudaliar, Sunder ;

Bhansali, Shipra ;

Sharma, Ratti Ram ;

Jha, Vivekanand ;

Marwaha, Neelam ;

Khandelwal, Niranjan ;

Srinivasan, Anand ;

Sachdeva, Naresh ;

Hawkins, Meredith ;

Bhansali, Anil .

STEM CELLS AND DEVELOPMENT, 2017, 26 (07) :471-481

[10] Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies [J].

Block, Travis J. ;

Marinkovic, Milos ;

Tran, Olivia N. ;

Gonzalez, Aaron O. ;

Marshall, Amanda ;

Dean, David D. ;

Chen, Xiao-Dong .

STEM CELL RESEARCH & THERAPY, 2017, 8

← 1 2 3 4 5 6 7 8 9 10 →